Cargando…

New Target for Precision Medicine Treatment of Giant-Cell Tumor of Bone: Sunitinib Is Effective in the Treatment of Neoplastic Stromal Cells with Activated PDGFRβ Signaling

SIMPLE SUMMARY: The purpose of this study was to analyze differential cell signaling in response to denosumab treatment to identify and subsequently inhibit molecular targets in the neoplastic stromal cell population, which poses a risk for tumor recurrence. Using phosphoprotein arrays, a distinct s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahdal, Michal, Neradil, Jakub, Mudry, Peter, Paukovcekova, Silvia, Staniczkova Zambo, Iva, Urban, Jiri, Macsek, Peter, Pazourek, Lukas, Tomas, Tomas, Veselska, Renata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305892/ https://www.ncbi.nlm.nih.gov/pubmed/34298757 http://dx.doi.org/10.3390/cancers13143543

Ejemplares similares

Proximal Tibia Tumour Location and Curettage Are Major Risk Factors of Local Recurrence in Giant Cell Tumour of Bone
por: Mahdal, Michal, et al.
Publicado: (2023)

Outcomes of Intercalary Endoprostheses as a Treatment for Metastases in the Femoral and Humeral Diaphysis
por: Mahdal, Michal, et al.
Publicado: (2022)

Serial Xenotransplantation in NSG Mice Promotes a Hybrid Epithelial/Mesenchymal Gene Expression Signature and Stemness in Rhabdomyosarcoma Cells
por: Skoda, Jan, et al.
Publicado: (2020)

Improved osteosarcoma survival with addition of mifamurtide to conventional chemotherapy – Observational prospective single institution analysis
por: Múdry, Peter, et al.
Publicado: (2021)

Iron-Chelation Treatment by Novel Thiosemicarbazone Targets Major Signaling Pathways in Neuroblastoma
por: Macsek, Peter, et al.
Publicado: (2021)

Effects of Sunitinib and Other Kinase Inhibitors on Cells Harboring a PDGFRB Mutation Associated with Infantile Myofibromatosis
por: Sramek, Martin, et al.
Publicado: (2018)

CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines
por: Sana, Jiri, et al.
Publicado: (2011)

Case report: rapid and durable response to PDGFR targeted therapy in a child with refractory multiple infantile myofibromatosis and a heterozygous germline mutation of the PDGFRB gene
por: Mudry, Peter, et al.
Publicado: (2017)

Total elbow replacement for giant-cell tumor of bone after denosumab treatment: a case report
por: Apostolopoulos, Vasileios, et al.
Publicado: (2023)

Thiosemicarbazones Can Act Synergistically with Anthracyclines to Downregulate CHEK1 Expression and Induce DNA Damage in Cell Lines Derived from Pediatric Solid Tumors
por: Paukovcekova, Silvia, et al.
Publicado: (2022)

Thiosemicarbazones and selected tyrosine kinase inhibitors synergize in pediatric solid tumors: NDRG1 upregulation and impaired prosurvival signaling in neuroblastoma cells
por: Krchniakova, Maria, et al.
Publicado: (2022)

Novel Thiosemicarbazones Sensitize Pediatric Solid Tumor Cell-Types to Conventional Chemotherapeutics through Multiple Molecular Mechanisms
por: Paukovcekova, Silvia, et al.
Publicado: (2020)

Nestin as a marker of cancer stem cells
por: Neradil, Jakub, et al.
Publicado: (2015)

Clinical outcomes and survival comparison between NexGen all-poly and its metal-backed equivalent in total knee arthroplasty
por: Apostolopoulos, Vasileios, et al.
Publicado: (2023)

Enhanced Antiproliferative Effect of Combined Treatment with Calcitriol and All-Trans Retinoic Acid in Relation to Vitamin D Receptor and Retinoic Acid Receptor α Expression in Osteosarcoma Cell Lines
por: Paukovcekova, Silvia, et al.
Publicado: (2020)

Nestin expression in the cell lines derived from glioblastoma multiforme
por: Veselska, Renata, et al.
Publicado: (2006)

Co-Expression of Cancer Stem Cell Markers Corresponds to a Pro-Tumorigenic Expression Profile in Pancreatic Adenocarcinoma
por: Skoda, Jan, et al.
Publicado: (2016)

DHFR-mediated effects of methotrexate in medulloblastoma and osteosarcoma cells: The same outcome of treatment with different doses in sensitive cell lines
por: NERADIL, JAKUB, et al.
Publicado: (2015)

Penis as a primary site of an extraskeletal Ewing sarcoma: A case report
por: Krakorova, Dagmar Adamkova, et al.
Publicado: (2021)

Rapid HPLC Method for Determination of Isomaltulose in the Presence of Glucose, Sucrose, and Maltodextrins in Dietary Supplements
por: Crha, Tomáš, et al.
Publicado: (2020)

Targeted treatment of severe vascular malformations harboring PIK3CA and TEK mutations with alpelisib is highly effective with limited toxicity
por: Sterba, Martin, et al.
Publicado: (2023)

Non-DHFR-mediated effects of methotrexate in osteosarcoma cell lines: epigenetic alterations and enhanced cell differentiation
por: Sramek, Martin, et al.
Publicado: (2016)

Nestin expression in osteosarcomas and derivation of nestin/CD133 positive osteosarcoma cell lines
por: Veselska, Renata, et al.
Publicado: (2008)

Sunitinib in the treatment of gastrointestinal stromal tumor: patient selection and perspectives
por: Mulet-Margalef, Nuria, et al.
Publicado: (2016)

Pneumatosis Cystoides Intestinalis Secondary to Sunitinib Treatment for Gastrointestinal Stromal Tumor
por: Asahi, Yoh, et al.
Publicado: (2018)

Individualization of Treatment Improves the Survival of Children With High-Risk Solid Tumors: Comparative Patient Series Analysis in a Real-Life Scenario
por: Kyr, Michal, et al.
Publicado: (2019)

NANOG/NANOGP8 Localizes at the Centrosome and is Spatiotemporally Associated with Centriole Maturation
por: Mikulenkova, Erika, et al.
Publicado: (2020)

Repurposing Tyrosine Kinase Inhibitors to Overcome Multidrug Resistance in Cancer: A Focus on Transporters and Lysosomal Sequestration
por: Krchniakova, Maria, et al.
Publicado: (2020)

Whole Exome Sequencing Identifies PHF14 Mutations in Neurocytoma and Predicts Responsivity to the PDGFR Inhibitor Sunitinib
por: Zhang, Dongyun, et al.
Publicado: (2022)

The ATRA-induced differentiation of medulloblastoma cells is enhanced with LOX/COX inhibitors: an analysis of gene expression
por: Chlapek, Petr, et al.
Publicado: (2014)

Molecular Modeling Study of c-KIT/PDGFRα Dual Inhibitors for the Treatment of Gastrointestinal Stromal Tumors
por: Keretsu, Seketoulie, et al.
Publicado: (2020)

Surgery after treatment with imatinib and/or sunitinib in patients with metastasized gastrointestinal stromal tumors: is it worthwhile?
por: Tielen, Ronald, et al.
Publicado: (2012)

Comprehensive Molecular Profiling for Relapsed/Refractory Pediatric Burkitt Lymphomas—Retrospective Analysis of Three Real-Life Clinical Cases—Addressing Issues on Randomization and Customization at the Bedside
por: Polaskova, Kristyna, et al.
Publicado: (2020)

Alternative schedules or integration strategies to maximise treatment duration with sunitinib in patients with gastrointestinal stromal tumours
por: SAPONARA, MARISTELLA, et al.
Publicado: (2014)

Sunitinib Treatment for Multiple Brain Metastases from Jejunal Gastrointestinal Stromal Tumor: Case Report
por: TAKEUCHI, Hayato, et al.
Publicado: (2014)

The power of natural phenolic compounds: caffeic acid is able to enhance the retinoid-induced differentiation of tumor cells
por: Veselska, Renata, et al.
Publicado: (2014)

Atypical nuclear localization of CD133 plasma membrane glycoprotein in rhabdomyosarcoma cell lines
por: NUNUKOVA, ALENA, et al.
Publicado: (2015)

Fractioned Dose Regimen of Sunitinib for Patients with Gastrointestinal Stromal Tumor: A Pharmacokinetic and Treatment Efficacy Study()
por: Chen, Yen-Yang, et al.
Publicado: (2014)

Treatment of gastrointestinal stromal tumours in paediatric and young adult patients with sunitinib: a multicentre case series
por: Rutkowski, Piotr, et al.
Publicado: (2017)

Phospho-Protein Arrays as Effective Tools for Screening Possible Targets for Kinase Inhibitors and Their Use in Precision Pediatric Oncology
por: Neradil, Jakub, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nj0tk7jm98jogsn6u81ijnl9bu